You are here >
Media & Events > Industry News > Greater Manchester healthcare factory ramps up production in fight against COVID-1921 April 2020
Categories: Life Science and Healthcare
Market-leading North West based healthcare company, Vernacare, has ramped up production by 60% to seven days a week at their largest production facility in Bolton, to meet an increased global demand of their products in the fight against COVID-19.
A large team of dedicated ‘keyworkers’ have worked around the clock and overcome logistical challenges to ensure the company’s range of infection control products - which minimise the risk of transmission from patient to healthcare worker - reach over 50 countries, worldwide.
Vernacare manufactures antimicrobial wipes that kill viruses within 15 seconds and the firm has also been supplying hospitals with disposable products for waste management from patient testing, toileting and bathing.
Currently their products are used in 95% of NHS hospitals and 30 of their disposal-waste machines have also recently been installed at the Nightingale hospital in Birmingham and a further 12 into Glasgow.
Hakeem Adebiyi, International Sales and Marketing Director of Vernacare, said:
“We’ve had to adapt as a business to the changes in the marketplace during these unprecedented times. Our range of products has a role to play in the healthcare setting to halt the spread of COVID-19 and as a result global demand has increased.
We have moved to seven days a week production at our sites in the North West and the response of our team has been magnificent. We are also working with our supply chain to ensure continuous supply of materials and consistency of quality.
We are experiencing increased demand from Spain, Italy, the Nordic countries but also Ireland, India, Australia, New Zealand and the Middle East as the spread of the virus continues.
Hakeem said:
“At the start of the outbreak, we worked with partners in the commonwealth office to supply product via their teams to Wuhan to help improve infection control rates in the epicentre of the virus outbreak.
We will continue to work with our partners to ensure we can deliver the products needed by the NHS and our international partners and in our small way, support them in the fight against this virus."